Special Interest Group 2021: Neurogenetics (recording)
*This activity is free of charge to those registered for ANA2021. Please click continue to access the content. Please contact us if you are prompted to pay the fee and were registered for the meeting.*
Description: Arguably no medical specialty has benefited more from the last decade of genomic advances than Neurology, and the pace of discoveries continued in 2021. This session aims to keep attendees up-to-date by providing key updates from four broad facets of neurogenetic inquiry: advances in methodologies; key gene discoveries; sociological and ethical implications of genetics; and exciting developments in molecular therapies.
Chair: Matthew Harms, MD, Columbia University
Co-Chair: Suman Jayadev, MD, University of Washington
Psychiatric Disorders and Neurodegenerative Diseases: Shared and Distinct Genetic Basis
Aliza Wingo MD, MSc
Comprehensive Analysis of PRKN in a Large Parkinson’s Disease Cohort and the UK Biobank Identifies Causative Mutations and Validates Population Scale Screening by Microarray
Derek Narendra MD, PhD
National Institute of Neurological Disorders and Stroke
RFC1-Associated Neurological Diseases
Mary Reilly, MB, Bch, BAO, MD, FRCP, FRCPI
University College London
- 1.50 AMA PRA Category 1 Credit™The American Neurological Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Neurological Association designates this Enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 Participation